Lv12
30 积分 2025-03-22 加入
Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia/osteoporosis in T2DM patients
3小时前
已完结
Association of Metabolic Dysfunction-Associated Fatty Liver Disease and Liver Stiffness With Bone Mineral Density in American Adults
3小时前
已完结
Increased BMD in SLD Patients Without Advanced Hepatic Fibrosis: Evidence From the NHANES 2017–2020 Database
3小时前
已完结
NAFLD and Liver Fibrosis Are Not Associated With Reduced Femoral Bone Mineral Density in the General US Population
3小时前
已关闭
Deciphering the cellular and molecular landscape of pulmonary fibrosis through single-cell sequencing and machine learning
3个月前
已完结
Advanced Progress of the Relationship Between Antihypertensive Drugs and Bone Metabolism
4个月前
已完结
Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process
5个月前
已完结
An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
5个月前
已完结
Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease – novel insights into cellular communication circuits
5个月前
已完结
Hepatic inflammatory responses in liver fibrosis
5个月前
已完结
皖公网安备34019202002308
